The findings suggest that reconsideration of current clinical guidelines, which support MRI only for symptomatic brain ...

Medically reviewed by Forest Miller, OTR/L When you are managing metastatic breast cancer, planning for the future is both ...

Several studies show that isolation is very common among those diagnosed with metastatic breast cancer. However, there are ...

After living with metastatic breast cancer for 11 years, I reflect on my journey and plan to embrace the coming year with ...

DelveInsight’s, “Metastatic Breast Cancer Pipeline Insight” report provides comprehensive insights about 100+ companies and ...

Caring for someone with metastatic breast cancer can be demanding physically, emotionally, and financially, but there are ...

Katrina Cooke and Ashley Dostefano share their personal journeys, reflecting on the challenges they faced, the victories they ...

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

The FDA expanded the approval of trastuzumab deruxtecan for treatment of breast cancer.The new indication applies to use of ...

An MP diagnosed with breast cancer for a second time wants to "debunk" misconceptions about metastatic cancers. Labour MP for ...